(Q42997420)

12 November 2017

title

Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation (English)

1 reference

12 November 2017

1 reference

liver transplantation

1 reference

1 reference

1 reference

S Mukherjee

1

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Transplantation Proceedings

12 November 2017

published in

1 reference

12 November 2017

volume

37

1 reference

12 November 2017

issue

10

1 reference

12 November 2017

page(s)

4403-4405

1 reference

Retransplantation for recurrent hepatitis C: Positive aspects

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.018

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.018

Liver transplantation and hepatitis C virus: systematic review of antiviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.018

Recurrent hepatitis C virus infection after liver transplantation: natural course, therapeutic approach and possible mechanisms of viral control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.018

Liver Transplantation and Hepatitis C. Proceedings of a consensus development symposium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.10.018

10.1016/J.TRANSPROCEED.2005.10.018

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference